What is the role of the pharmaceutical industry in addressing the challenge of antibiotic resistance and developing new antimicrobials for pathogens like Pseudomonas aeruginosa?

Pseudomonas aeruginosa is rarely involved in this type of infections. However, the literature presents cases of this organism causing endophthalmitis post ... Antibiotics with a novel mode of action will be needed to avoid cross resistance against currently used therapeutic agents. Importantly, antivirulence drugs are ... The bacteria are found widely in the environment, such as in soil, water, and plants. They usually do not cause infections in healthy people. If an infection ... Event Description ... 2nd Hands on workshop on Pseudomonas aeruginosa resistance phenotypes and whole genome sequence resistome analysis. Practical course ... Objective. Investigate clonal dissemination of nosocomial multidrug-resistant Pseudomonas aeruginosa isolates within and between Brazilian intensive care ... Oct 12, 2022 ... PAO1 and PA14 are common laboratory reference strains, modeling moderately and hyper-virulent phenotypes, respectively. Nov 5, 2024 ... Pseudomonas aeruginosa has become an important cause of infection, especially in patients with compromised host defense mechanisms. It is the ... Abstract. Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen and a model bacterium for studying virulence and bacterial social traits. While it ... Jan 20, 2023 ... Pseudomonas aeruginosa is an opportunistic pathogen that requires iron for growth and virulence, yet this nutrient is sequestered by the ... Our results suggest that ExoS facilitates P. aeruginosa penetration through the intestinal epithelial barrier by binding to FXYD3 and thereby impairing the ...